Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
about
Current and emerging azole antifungal agentsVirulence-Associated Enzymes of Cryptococcus neoformansCryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomesGlobal transcriptome profile of Cryptococcus neoformans during exposure to hydrogen peroxide induced oxidative stressClinical, cellular, and molecular factors that contribute to antifungal drug resistance.Heteroresistance of Cryptococcus gattii to fluconazole.Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.Regulatory circuitry governing fungal development, drug resistance, and disease.Drug strategies targeting CYP51 in neglected tropical diseasesIdentification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans.Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.Fluconazole-Induced Ploidy Change in Cryptococcus neoformans Results from the Uncoupling of Cell Growth and Nuclear Division.Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistanceEfflux-mediated antifungal drug resistance.Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function.Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutantsIdentification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans.G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
P2860
Q24550733-19C3BABA-FD7B-4675-8C2E-EE3690E0942FQ26785005-CCE7890A-FB20-44AE-B8EB-37307D784A65Q27315103-3C5812FD-2DBE-49D5-89C6-E50F62043052Q28485327-FFA8698A-80AD-4361-ADAF-F0593E0D1C35Q33721804-EE1E5A97-C020-48B9-B935-47CC35C8E804Q33876577-33F71A74-81DA-45B6-976F-35BAFC473FFDQ33977302-240B57E3-F2CE-4467-82D3-1642715CA517Q34190284-137EDBA0-B8C1-4538-B2EA-0FB7785C4EE9Q34622554-8F54CF96-6E87-43C4-A222-16544B059CDBQ35806201-945C69C3-6338-43DE-893C-9C8CF362D3E8Q35854764-611D1A3D-911E-47F9-AA14-81B226D297AEQ36364064-BB720E04-34B8-43BF-985F-73FE0A51DEEAQ36409929-8558615F-FE09-41B4-9942-9BD3868F3FA1Q37122826-3A244D77-E6DE-427B-9330-AD0C4149720FQ37156645-76D77DFA-9A9D-47FD-A4BA-6B1E44354262Q37247728-CDB41013-AC72-4C9B-A4DE-7609B1C28F58Q39493735-42024512-8413-4963-B433-CCC420D17189Q39558473-0038F419-217A-4173-B0AD-4B809009217FQ39670853-AE7249E4-ABE8-4748-B667-9DDA0B68DC8EQ39732812-36648C80-89AF-40F2-BA4E-A06ACD50E3F9Q40130606-CE0BEED6-3CC8-4CB7-87BF-5ACF6CF7DCED
P2860
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
@ast
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
@en
type
label
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
@ast
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
@en
prefLabel
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
@ast
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans.
@en
P2093
P2860
P356
P1476
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans
@en
P2093
Manning NJ
Rinaldi MG
Venkateswarlu K
P2860
P304
P356
10.1128/AAC.41.4.748
P407
P577
1997-04-01T00:00:00Z